TMZ, Temozolomide, RNASynthesis, RNA Synthesis, TZM, Autophagy, Apoptosis, CCRG 81045, CCRG81045, CCRG-81045, DNASynthesis, DNA Synthesis, DNAAlkylator, DNA replication, DNA Alkylator, DNA Alkylator/Crosslinker, Crosslinker, NSC362856, NSC-362856, inhibit, NSC 362856, Inhibitor
Temozolomide is an orally bioavailable DNA alkylating agent capable of crossing the blood-brain barrier. It exhibits antitumor, antiangiogenic, and pro-apoptotic properties and is widely used in glioblastoma research, both in vitro and in vivo, due to its stability in acidic conditions and hydrolysis at neutral to basic pH.
Molekulargewicht:
194.15
Reinheit:
99.87% (May vary between batches)
CAS Nummer:
[85622-93-1]
Formel:
C6H6N6O2
Target-Kategorie:
DNA Alkylator/Crosslinker,Apoptosis,Autophagy,DNA/RNA Synthesis
